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Man, dog, pig: 
  5-HT4 receptors present on enteric choli-
nergic neurons innervating smooth muscle 
cells 
  activation of those 5-HT4 receptors by a 
 5-HT4 receptor agonist (e.g. prucalopride) 
   => ↑ ongoing acetylcholine release 
    => ↑ smooth muscle contraction 
 
 
 
 
 
Pig: 
  5-HT4 receptor pathway in enteric choli-
nergic neurons is controlled by phospho-
diesterase (PDE) 4  
 PDE4 inhibition 
  => contractions, facilitated by prucalo- 
   pride, are further enhanced 
Aim: 
Mouse: 5-HT4 receptors on enteric choliner-
gic neurons innervating smooth muscle cells 
+ control by phosphodiesterases? 
 circular smooth muscle strips from murine fundus, jejunum and colon 
 organ bath with oxygenated Krebs solution: 
 + guanethidine (4 µM) 
 + L-NAME (300 µM) 
 + MRS 2500 (1 µM; only for colon) 
 isometric tension recording 
 electrical field stimulation (EFS): 
 - 10 s train 
 - 500 µs pulse duration 
 - 4 (fundus) or 8 Hz (jejunum + colon) 
 - 5 (fundus + colon) or 10 min (jejunum) 
  intertrain interval 
 - Vmax = 30 V  voltage reduced till a  
  response of 50% 
 => EFS-induced submaximal neurogenic 
cholinergic on-contractions 
 contractions expressed as % of the mean 
amplitude of 5 contractions before pruca-
lopride, GR113808 or IBMX 
1. PRUCALOPRIDE = 5-HT4 receptor agonist 
colon 
3. IBMX = non-selective phosphodiesterase inhibitor 
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In murine fundus, jejunum and colon:  
 5-HT4 receptors 
  -  are present on cholinergic neurons innervating circular 
   smooth muscle cells 
 -  activation enhances electrically induced cholinergic  
  contractions 
 phosphodiesterases (PDEs)  
  -  are present in circular smooth muscle cells 
  -  PDE inhibition induces relaxation 
 
In murine fundus: 
 5-HT4 receptor pathway in enteric cholinergic neurons is con-
trolled by PDEs 
 mild PDE inhibition enhances the facilitating effect of pruca-
lopride 
 
In murine jejunum and colon: 
 no evidence for PDE-mediated control of the 5-HT4 receptor 
pathway in enteric cholinergic neurons was yet obtained 
 further investigation with selective PDE inhibitors is necessary 
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